Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 87, 31-42
Abstract
No abstract availableKeywords
Funding Information
- National Center of Excellence for Melon at the Vegetable and Fruit Improvement Center of Texas A&M University
This publication has 38 references indexed in Scilit:
- Evaluation of bitter melon (Momordica charantia) cultivars grown in Texas and levels of various phytonutrientsJournal of the Science of Food and Agriculture, 2018
- Organocatalyzed Novel Synthetic Methodology for Highly Functionalized Piperidines as Potent α‐Glucosidase InhibitorsArchiv der Pharmazie, 2016
- Separation and Identification of Cucurbitane-Type Triterpenoids from Bitter MelonACS Symposium Series, 2014
- Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potencyAsian Pacific Journal of Tropical Disease, 2013
- Cucurbitane Triterpenoids from the Leaves of Momordica charantia, and Their Cancer Chemopreventive Effects and CytotoxicitiesChemistry & Biodiversity, 2012
- American ginseng: Potential structure–function relationship in cancer chemopreventionBiochemical Pharmacology, 2010
- Momordica charantia Constituents and Antidiabetic Screening of the Isolated Major CompoundsChemical and Pharmaceutical Bulletin, 2006
- The structure of human pancreaticα-amylase at 1.8 Å resolution and comparisons with related enzymesProtein Science, 1995
- The Active Center of a Mammalian .alpha.-Amylase. Structure of the Complex of a Pancreatic .alpha.-Amylase with a Carbohydrate Inhibitor Refined to 2.2-.ANG. ResolutionBiochemistry, 1994
- New Cucurbitane Triterpenoids from Momordica charantiaJournal of Natural Products, 1990